BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

727 related articles for article (PubMed ID: 21767407)

  • 21. Evaluation of etoricoxib in patients undergoing total knee replacement surgery in a double-blind, randomized controlled trial.
    Rawal N; Viscusi E; Peloso PM; Minkowitz HS; Chen L; Shah S; Mehta A; Chitkara DK; Curtis SP; Papanicolaou DA
    BMC Musculoskelet Disord; 2013 Oct; 14():300. PubMed ID: 24156640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is there any analgesic benefit from preoperative vs. postoperative administration of etoricoxib in total knee arthroplasty under spinal anaesthesia?: A randomised double-blind placebo-controlled trial.
    Munteanu AM; Cionac Florescu S; Anastase DM; Stoica CI
    Eur J Anaesthesiol; 2016 Nov; 33(11):840-845. PubMed ID: 27454662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. No effect of the cyclooxygenase-2 inhibitor etoricoxib on pre-emptive and post-operative analgesia in visceral surgery: results of a randomized controlled trial.
    Fleckenstein J; Kohls N; Evtouchenko E; Lehmeyer L; Kramer S; Lang PM; Siebeck M; Mussack T; Hatz R; Heindl B; Conzen P; Rehm M; Czerner S; Zwißler B; Irnich D
    Eur J Pain; 2016 Feb; 20(2):186-95. PubMed ID: 25828692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Efficiency and safety of different etoricoxib regimens in patients with axial spondyloarthritis, including ankylosing spondylitis].
    Gaydukova IZ; Rebrov AP
    Ter Arkh; 2015; 87(3):77-82. PubMed ID: 26027245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Further assessment of the clinically effective dose range of etoricoxib: a randomized, double-blinded, placebo-controlled trial in rheumatoid arthritis.
    Greenwald M; Peloso PM; Mandel D; Soto O; Mehta A; Frontera N; Boice JA; Zhan XJ; Curtis SP
    Curr Med Res Opin; 2011 Oct; 27(10):2033-42. PubMed ID: 21905970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of gastroprotective agents and discontinuations due to dyspepsia with the selective cyclooxygenase-2 inhibitor etoricoxib compared with non-selective NSAIDs.
    Watson DJ; Bolognese JA; Yu C; Krupa D; Curtis S
    Curr Med Res Opin; 2004 Dec; 20(12):1899-908. PubMed ID: 15701208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the efficacy and safety of etoricoxib compared with naproxen in two, 138-week randomised studies of patients with osteoarthritis.
    Reginster JY; Malmstrom K; Mehta A; Bergman G; Ko AT; Curtis SP; Reicin AS
    Ann Rheum Dis; 2007 Jul; 66(7):945-51. PubMed ID: 17142385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of two doses of etoricoxib, a COX-2 selective non-steroidal anti-inflammatory drug (NSAID), in the treatment of Rheumatoid Arthritis in a double-blind, randomized controlled trial.
    Bickham K; Kivitz AJ; Mehta A; Frontera N; Shah S; Stryszak P; Popmihajlov Z; Peloso PM
    BMC Musculoskelet Disord; 2016 Aug; 17():331. PubMed ID: 27502582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minimum efficacy criteria for comparisons between treatments using individual patient meta-analysis of acute pain trials: examples of etoricoxib, paracetamol, ibuprofen, and ibuprofen/paracetamol combinations after third molar extraction.
    Moore AR; Straube S; Paine J; Derry S; McQuay HJ
    Pain; 2011 May; 152(5):982-989. PubMed ID: 21414722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Intravenous Golimumab on Fatigue and the Relationship with Clinical Response in Adults with Active Ankylosing Spondylitis in the Phase 3 GO-ALIVE Study.
    Deodhar A; Shiff NJ; Gong C; Chan EKH; Hsia EC; Lo KH; Akawung A; Kim L; Xu S; Reveille JD
    Rheumatol Ther; 2023 Aug; 10(4):983-999. PubMed ID: 37322274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The analgesic effect of etoricoxib relative to that of cetaminophen analgesics: a randomized, controlled single-dose study in acute dental impaction pain.
    Malmstrom K; Ang J; Fricke JR; Shingo S; Reicin A
    Curr Med Res Opin; 2005 Jan; 21(1):141-9. PubMed ID: 15881486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of etoricoxib and celecoxib for pain prevention after periodontal surgery: a double-masked, parallel-group, placebo-controlled, randomized clinical trial.
    Steffens JP; Santos FA; Pilatti GL
    J Periodontol; 2011 Sep; 82(9):1238-44. PubMed ID: 21235334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-Steroidal Anti-Inflammatory Drug Etoricoxib Facilitates the Application of Individualized Exercise Programs in Patients with Ankylosing Spondylitis.
    Marcu IR; Dop D; Padureanu V; Niculescu SA; Padureanu R; Niculescu CE; Rogoveanu OC
    Medicina (Kaunas); 2020 May; 56(6):. PubMed ID: 32486104
    [No Abstract]   [Full Text] [Related]  

  • 34. Relative efficacy and tolerability of etoricoxib, celecoxib, and naproxen in the treatment of osteoarthritis : A Bayesian network meta-analysis of randomized controlled trials based on patient withdrawal.
    Song GG; Seo YH; Kim JH; Choi SJ; Ji JD; Lee YH
    Z Rheumatol; 2016 Jun; 75(5):508-16. PubMed ID: 26768273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the dose range of etoricoxib in an acute pain setting using the postoperative dental pain model.
    Daniels SE; Bandy DP; Christensen SE; Boice J; Losada MC; Liu H; Mehta A; Peloso PM
    Clin J Pain; 2011 Jan; 27(1):1-8. PubMed ID: 21188849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Etoricoxib.
    Cochrane DJ; Jarvis B; Keating GM
    Drugs; 2002; 62(18):2637-51; discussion 2652-3. PubMed ID: 12466002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Etoricoxib for pain management during thyroid surgery--a prospective, placebo-controlled study.
    Smirnov G; Terävä M; Tuomilehto H; Hujala K; Seppänen M; Kokki H
    Otolaryngol Head Neck Surg; 2008 Jan; 138(1):92-7. PubMed ID: 18165000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal effects of etoricoxib and comparator nonsteroidal anti-inflammatory drugs in controlled clinical trials.
    Curtis SP; Ng J; Yu Q; Shingo S; Bergman G; McCormick CL; Reicin AS
    Clin Ther; 2004 Jan; 26(1):70-83. PubMed ID: 14996519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Etoricoxib in ankylosing spondylitis: is there a role for active patients refractory to traditional NSAIDs?
    Gratacós J; Moreno Martínez-Losa M; Font P; Montilla C; Fernández-Espartero C; Linares LF; Brito E; Oliva JC; Collantes-Estevez E;
    Clin Exp Rheumatol; 2016; 34(1):94-9. PubMed ID: 26812050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pooled analysis of thrombotic cardiovascular events in clinical trials of the COX-2 selective Inhibitor etoricoxib.
    Curtis SP; Ko AT; Bolognese JA; Cavanaugh PF; Reicin AS
    Curr Med Res Opin; 2006 Dec; 22(12):2365-74. PubMed ID: 17265571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.